Important Update on FDA Changes Concerning Peptides

Important Update on FDA Changes Concerning Peptides

**PRESS RELEASE**

**Important Update on FDA Changes Concerning Peptides**

We are writing to you with an important update concerning recent changes by the FDA. The FDA has recently made a public statement regarding Category 2 of bulk drug substances, focusing on Peptides. The full details can be found in the article. Click Here

While we have been monitoring the situation around peptides and the FDA for several years, this particular decision came as a surprise to us. It seems as though this significant change took place almost overnight.

Please be assured that Nuceria remains steadfast in our commitment to delivering the highest quality compounded medications. Our ethos is built upon integrity. We have always sourced our peptides from FDA-approved facilities and take pride in partnering only with FDA-registered peptide manufacturers.

**Immediate Changes in Medication Availability**

In light of the FDA's recent statement, Nuceria Pharmacy will cease production of all peptides containing the following active ingredients:

- AOD 9604 
- BPC-157 
- CJC-1295 
- Dihexa
- DSIP 
- Epitalon  
- GHK-Cu (for injectable routes of administration)  
- Ibutamoren (MK677)
- Ipamorelin Acetate 
- Kisspeptin-10 
- KPV 
- MOTs-C 
- Selank
- Semax

We understand the potential implications this might have for your treatment plans. However, Nuceria Health remains unwavering in our belief in the highest standards of safety and quality for our compounds. Your safety, health, and well-being continue to be our topmost priority.

We recognize that many of you have pressing questions and concerns. While we have been overwhelmed with inquiries, we would like to note that our current knowledge is limited to the details provided in the linked article. We request your understanding and patience as we navigate this new landscape.

Stay tuned for a follow-up email in the coming weeks. We are working diligently to provide you with alternative medication options to ensure a smooth transition for all our patients.

Thank you for placing your trust in Nuceria Health. We are in this together and remain dedicated to serving your health needs with the utmost care and professionalism.

Warm regards,

Nuceria Health Team

---

Request an appointment here: https://mynuceria.com or call Nuceria Health at (305) 398-4370 for an appointment in our Miami office.
Check out what others are saying about our services on Yelp: Wellness Center in Miami, FL.

Related Posts: